These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 7719440

  • 21. Phenylalanine ammonia-lyase immobilized in microcapsules for the depletion of phenylalanine in plasma in phenylketonuric rat model.
    Bourget L, Chang TM.
    Biochim Biophys Acta; 1986 Oct 01; 883(3):432-8. PubMed ID: 3756210
    [Abstract] [Full Text] [Related]

  • 22. Trends in enzyme therapy for phenylketonuria.
    Kim W, Erlandsen H, Surendran S, Stevens RC, Gamez A, Michols-Matalon K, Tyring SK, Matalon R.
    Mol Ther; 2004 Aug 01; 10(2):220-4. PubMed ID: 15294168
    [Abstract] [Full Text] [Related]

  • 23. Plasma/intestinal concentration patterns suggestive of entero-portal recirculation of amino acids: effects of oral administration of asparaginase, glutaminase and tyrosinase immobilized by microencapsulation in artificial cells.
    Chang TM, Lister C.
    Biomater Artif Cells Artif Organs; 2004 Aug 01; 16(5):915-26. PubMed ID: 3150943
    [Abstract] [Full Text] [Related]

  • 24. Entrapment of phenylalanine ammonia-lyase in silk fibroin for protection from proteolytic attack.
    Inoue S, Matsunaga Y, Iwane H, Sotomura M, Nose T.
    Biochem Biophys Res Commun; 1986 Nov 26; 141(1):165-70. PubMed ID: 3800993
    [Abstract] [Full Text] [Related]

  • 25. [Utilization of excess phenylalanine in the diet of rats to obtain an experimental model of phenylketonuria].
    Isacheva NT, Ekimovskiĭ AP.
    Vopr Pitan; 1975 Nov 26; (1):40-4. PubMed ID: 1239862
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Effects of dietary mixtures of amino acids on fetal growth and maternal and fetal amino acid pools in experimental maternal phenylketonuria.
    Austic RE, Su CL, Strupp BJ, Levitsky DA.
    Am J Clin Nutr; 1999 Apr 26; 69(4):687-96. PubMed ID: 10197570
    [Abstract] [Full Text] [Related]

  • 29. Induction, titration, and maintenance dosing regimen in a phase 2 study of pegvaliase for control of blood phenylalanine in adults with phenylketonuria.
    Zori R, Thomas JA, Shur N, Rizzo WB, Decker C, Rosen O, Li M, Schweighardt B, Larimore K, Longo N.
    Mol Genet Metab; 2018 Nov 26; 125(3):217-227. PubMed ID: 30146451
    [Abstract] [Full Text] [Related]

  • 30. A new therapy prevents intellectual disability in mouse with phenylketonuria.
    Pascucci T, Rossi L, Colamartino M, Gabucci C, Carducci C, Valzania A, Sasso V, Bigini N, Pierigè F, Viscomi MT, Ventura R, Cabib S, Magnani M, Puglisi-Allegra S, Leuzzi V.
    Mol Genet Metab; 2018 May 26; 124(1):39-49. PubMed ID: 29661557
    [Abstract] [Full Text] [Related]

  • 31. In vivo safety of hollow fiber enzyme-reactors with immobilized phenylalanine ammonia-lyase in a large animal model for phenylketonuria.
    Ambrus CM, Sharma SD, Horváth C, Kalghatgi K, Anthone S, Ambrus JL, Cooley C, Mirand EA.
    J Pharmacol Exp Ther; 1983 Mar 26; 224(3):598-602. PubMed ID: 6681841
    [Abstract] [Full Text] [Related]

  • 32. Biochemical effects of induced phenylketonuria in rats.
    Poncet IB, Berry HK, Butcher RE, Kazmaier KJ.
    Biol Neonate; 1975 Mar 26; 26(1-2):88-101. PubMed ID: 125115
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Pegvaliase for the treatment of phenylketonuria: A pivotal, double-blind randomized discontinuation Phase 3 clinical trial.
    Harding CO, Amato RS, Stuy M, Longo N, Burton BK, Posner J, Weng HH, Merilainen M, Gu Z, Jiang J, Vockley J, PRISM-2 Investigators.
    Mol Genet Metab; 2018 May 26; 124(1):20-26. PubMed ID: 29628378
    [Abstract] [Full Text] [Related]

  • 35. Development of pegylated forms of recombinant Rhodosporidium toruloides phenylalanine ammonia-lyase for the treatment of classical phenylketonuria.
    Gámez A, Sarkissian CN, Wang L, Kim W, Straub M, Patch MG, Chen L, Striepeke S, Fitzpatrick P, Lemontt JF, O'Neill C, Scriver CR, Stevens RC.
    Mol Ther; 2005 Jun 26; 11(6):986-9. PubMed ID: 15922970
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Inhibiting neutral amino acid transport for the treatment of phenylketonuria.
    Belanger AM, Przybylska M, Gefteas E, Furgerson M, Geller S, Kloss A, Cheng SH, Zhu Y, Yew NS.
    JCI Insight; 2018 Jul 26; 3(14):. PubMed ID: 30046012
    [Abstract] [Full Text] [Related]

  • 38. Phenylketonuria: old disease, new approach to treatment.
    Levy HL.
    Proc Natl Acad Sci U S A; 1999 Mar 02; 96(5):1811-3. PubMed ID: 10051548
    [No Abstract] [Full Text] [Related]

  • 39. The relationship between dietary intake, growth and body composition in Phenylketonuria.
    Evans M, Truby H, Boneh A.
    Mol Genet Metab; 2017 Sep 02; 122(1-2):36-42. PubMed ID: 28739202
    [Abstract] [Full Text] [Related]

  • 40. Enzymatic control of phenylalanine intake in phenylketonuria.
    Hoskins JA, Jack G, Wade HE, Peiris RJ, Wright EC, Starr DJ, Stern J.
    Lancet; 1980 Feb 23; 1(8165):392-4. PubMed ID: 6101846
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.